Prospects for gene therapy in inflammatory arthritis

Area of Science:

• * Rheumatology and Immunology
• * Molecular Biology and Genetics

Background:

• * Rheumatoid arthritis (RA) is a chronic autoimmune disease requiring novel therapeutic strategies.
• * Current treatments like biologics often require frequent administration and may lack joint specificity.

Purpose of the Study:

• * To explore innovations in gene therapy for rheumatoid arthritis (RA) treatment.
• * To evaluate the potential of gene therapy as an alternative to existing biologic treatments.

Main Methods:

• * Review of gene therapy principles, including vector, promoter, and target gene innovations.
• * Analysis of gene therapy strategies such as overexpression of therapeutic genes and underexpression via small interfering RNA (siRNA).
• * Examination of proof-of-principle studies in animal models of arthritis.

Main Results:

• * Gene therapy demonstrates potential for advantageous RA treatment in animal models.
• * Advantages include joint-specific targeting and long-term expression of anti-arthritic molecules.
• * Gene therapy can potentially replace frequent recombinant protein administration.

Conclusions:

• * Gene therapy represents a promising strategy for rheumatoid arthritis management.
• * Further development and clinical trials are necessary to optimize gene therapy approaches for RA.
• * Innovations in vectors, promoters, and target genes are crucial for successful clinical translation.